Ridgetech, Inc. (RDGT)vsScienture Holdings, Inc. (SCNX)
RDGT
Ridgetech, Inc.
$1.80
-7.22%
HEALTHCARE · Cap: $1.27M
SCNX
Scienture Holdings, Inc.
$0.36
-5.26%
HEALTHCARE · Cap: $14.33M
Smart Verdict
WallStSmart Research — data-driven comparison
Ridgetech, Inc. generates 25008% more annual revenue ($119.94M vs $477,680). RDGT leads profitability with a 10.3% profit margin vs 0.0%. RDGT earns a higher WallStSmart Score of 37/100 (F).
RDGT
Hold37
out of 100
Grade: F
SCNX
Avoid33
out of 100
Grade: F
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Intrinsic value data unavailable for RDGT.
Margin of Safety
+21.4%
Fair Value
$0.57
Current Price
$0.36
$0.21 discount
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Reasonable price relative to book value
Every $100 of equity generates 30 in profit
Conservative balance sheet, low leverage
Reasonable price relative to book value
Revenue surging 449.1% year-over-year
Conservative balance sheet, low leverage
Areas to Watch
0.0% earnings growth
Smaller company, higher risk/reward
Revenue declined 11.7%
Distress zone — elevated risk
0.0% earnings growth
Smaller company, higher risk/reward
0.0% margin — thin
ROE of -0.1% — below average capital efficiency
Comparative Analysis Report
WallStSmart ResearchBull Case : RDGT
The strongest argument for RDGT centers on Price/Book, Return on Equity, Debt/Equity.
Bull Case : SCNX
The strongest argument for SCNX centers on Price/Book, Revenue Growth, Debt/Equity. Revenue growth of 449.1% demonstrates continued momentum.
Bear Case : RDGT
The primary concerns for RDGT are EPS Growth, Market Cap, Revenue Growth.
Bear Case : SCNX
The primary concerns for SCNX are EPS Growth, Market Cap, Profit Margin.
Key Dynamics to Monitor
RDGT profiles as a declining stock while SCNX is a hypergrowth play — different risk/reward profiles.
SCNX is growing revenue faster at 449.1% — sustainability is the question.
RDGT generates stronger free cash flow (5M), providing more financial flexibility.
Monitor PHARMACEUTICAL RETAILERS industry trends, competitive dynamics, and regulatory changes.
Bottom Line
RDGT scores higher overall (37/100 vs 33/100). SCNX offers better value entry with a 21.4% margin of safety. Both earn "Hold" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Ridgetech, Inc.
HEALTHCARE · PHARMACEUTICAL RETAILERS · USA
China Jo-Jo Drugstores, Inc. is a retailer and wholesale distributor of pharmaceutical and other healthcare products in the People's Republic of China. The company is headquartered in Hangzhou, the People's Republic of China.
Visit Website →Scienture Holdings, Inc.
HEALTHCARE · PHARMACEUTICAL RETAILERS · USA
Scienture Holdings, Inc. (SCNX) is a biotechnology firm focused on developing advanced therapeutic solutions for neurological disorders, utilizing an innovative drug development pipeline backed by a skilled research team. With a strong emphasis on addressing unmet medical needs, Scienture is poised to enhance patient outcomes while navigating the complexities of regulatory pathways. The company’s dedication to scientific rigor and its strategic partnerships not only bolster its growth potential but also position SCNX as a significant contributor to advancements in global healthcare. As the demand for effective neurological treatments grows, Scienture aims to leverage emerging opportunities within the expanding healthcare landscape.
Compare with Other PHARMACEUTICAL RETAILERS Stocks
Want to dig deeper into these stocks?